Hannah Vennard

Hannah Vennard

Auto-generated profile, based on publicly available information

Hannah Vennard

Department of Paediatric Respiratory and Sleep Medicine, Royal Hospital for Children, Glasgow, UK

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 April 2024 in European Respiratory Review
Verified
Journal Article
Open access
PDF file
HVHannah Vennard
Hannah Vennard
EBElise Buchan
Elise Buchan
PDPhilip Davies
Philip Davies
NGNeil Gibson
Neil Gibson
DLDavid Lowe
David Lowe
RLRoss Langley
Ross Langley
Paediatric sleep diagnostics is performed using complex multichannel tests in specialised centres, limiting access and availability and resulting in delayed diagnosis and management. Such investigations are often challenging due to patient size (prematurity), tolerability, and compliance with “gold standard” equipment. Children with sensory/behavioural issues, at increased risk of sleep disordered breathing (SDB), often find standard diagnostic equipment difficult.SDB can have implications for a child both in terms of physical health and neurocognitive development. Potential sequelae of untreated SDB includes failure to thrive, cardiopulmonary disease, impaired learning and behavioural issues. Prompt and accurate diagnosis of SDB is important to facilitate early intervention and improve outcomes.The current gold-standard diagnostic test for SDB is polysomnography (PSG), which is expensive, requiring the interpretation of a highly specialised physiologist. PSG is not feasible in low-income countries or outwith specialist sleep centres. During the coronavirus disease 2019 pandemic, efforts were made to improve remote monitoring and diagnostics in paediatric sleep medicine, resulting in a paradigm shift in SDB technology with a focus on automated diagnosis harnessing artificial intelligence (AI). AI enables interrogation of large datasets, setting the scene for an era of “sleep-omics”, characterising the endotypic and phenotypic bedrock of SDB by drawing on genetic, lifestyle and demographic information. The National Institute for Health and Care Excellence recently announced a programme for the development of automated home-testing devices for SDB. Scorer-independent scalable diagnostic approaches for paediatric SDB have potential to improve diagnostic accuracy, accessibility and patient tolerability; reduce health inequalities; and yield downstream economic and environmental benefits.

31 August 2025 in BMJ Open
Verified
Journal Article
Open access
PDF file
HVHannah Vennard
Hannah Vennard
EBElise Buchan
Elise Buchan
JMJennifer Miller
Jennifer Miller
SKStuart Kelly
Stuart Kelly
CCCatriona Cowan
Catriona Cowan
RLRoss Langley
Ross Langley
Introduction Accurate evaluation of respiratory rate and pattern is important in health and disease; however, it can be challenging in children and babies due to small size and poor tolerability of existing monitoring equipment. This protocol outlines a study evaluating the feasibility of collecting respiratory data using a chest-worn accelerometer-based motion sensor in paediatric patients at risk of apnoea, respiratory failure and sudden death. Methods and analysis This is an observational feasibility study over a 2-year period. The biosensor is an accelerometer worn on an ECG electrode during standard care at the Royal Hospital for Children, Glasgow. We aim to recruit three groups of patients (75 patients to each group): (1) Children attending for overnight cardiorespiratory polygraphy (0 to ≤16 years), (2) neonatal inpatients (from 30 weeks gestation) and (3) children attending for video telemetry at the epilepsy monitoring unit (0 to ≤16 years). Measurements will include (1) chest and/or abdominal wall motion measured by the worn biosensors; (2) standard clinical monitoring data will be collected to support biosensor data interpretation and (3) acceptability will be measured by a feedback questionnaire completed by patients and their parents/guardians. Ethics and dissemination This study protocol was reviewed and approved by Yorkshire and The Humber-Leeds East Research Ethics Committee, approval number 314 696. This study involves human participants; written informed consent and assent, when appropriate, will be obtained from participants (or their parent/legal guardian/next of kin) to participate in the study. The study will be carried out in accordance with the World Medical Association Declaration of Helsinki (1964) standard reporting. Study findings will be reported clearly and transparently with relevant stakeholders including researchers, practitioners and publicly available databases. Results from this study will be presented at national and international conferences and reported in peer-reviewed publications. Trial registration number NCT06292299 pre-results stage.

11 August 2025 in Archives of Disease in Childhood
Verified
Journal Article
Closed access
HVHannah Vennard
Hannah Vennard
ASAnna Selby
Anna Selby
MAMenaga Ananthamoorthy
Menaga Ananthamoorthy
EBElise Buchan
Elise Buchan
PBPaul Burns
Paul Burns
RLRoss Langley
Ross Langley
Background and objective: Cardiorespiratory polygraphy (CRP) is the predominant technology used to diagnose obstructive sleep apnoea (OSA) in tertiary centres in the UK. Nocturnal pulse oximetry (NPO) is cheaper and more accessible. This study evaluates NPO indices’ ability to predict OSA in children with Down syndrome (DS). Methods: Indices from simultaneous NPO and CRP recordings were compared in children with DS (aged 2–16 years) referred to evaluate OSA in two tertiary centres across an 8-year period. Receiver operating characteristic curves assessed the diagnostic accuracy of NPO indices, including ODI3 (3% Oxygen Desaturation Index) and ODI4 (4% Oxygen Desaturation Index). Two-by-two tables determined the sensitivities and specificities of cut-off values for predicting OSA. Results: 387 children with DS were included with stand-alone NPO; 177 female (46.7%), median age 6.1 years (range 2.02–15.97). There were 265 children (68.5%) with Obstructive Apnoea–Hypopnoea Index (OAHI) ≥1/hour, 164 with OAHI ≥1<5/hour (42.4%), 51 with OAHI ≥5<10/hour (13.2%) and 50 with OAHI ≥10/hour (12.9%). ODI3 and ODI4 demonstrated the best predictive value for predicting OSA. An ODI3 ≥19/hour and an ODI4 ≥8/hour were associated with the highest combined sensitivity (59.2%/63.8%) and specificity (74.6%/71.3%), respectively. Conclusion: Raised ODI3 and ODI4 predict moderate and severe OSA in children with DS with moderate specificity/sensitivity and have a low sensitivity for detecting mild OSA. The poor predictive performance of oximetry reflects the multifactorial nature of sleep disordered breathing in children with DS. We recommend oximetry is not used for diagnosis of OSA in DS and CRP/polysomnography should be used.

27 October 2022 in Endocrine Abstracts
Verified
Journal Article
Closed access
HVHannah Vennard
Hannah Vennard
YDYsaline Duvieusart
Ysaline Duvieusart
JMJane McNeilly
Jane McNeilly
AKAndrew Kernohan
Andrew Kernohan
Introduction: Thyroid storm, a life-threatening endocrine emergency, requires prompt intervention and treatment to improve outcomes. The diagnosis is made clinically, based on symptoms including hyperpyrexia, tachycardia, nausea, diarrhoea and altered cognition. The Burch-Wartofsky (BW) score is a symptom-based score recommended to determine the likelihood of thyroid storm. This retrospective study aims to determine use of the BW scale and its effect on management. Data collection: The CHI numbers of inpatients with significantly elevated fT4 (>25 pmo/l) at the QEUH labs between Jan-21 and Nov-21 were obtained via Laboratory Information System (LIMS) search. Patients in the maternity, oncology unit, on levothyroxine or with detectable TSH were excluded. Information included: descriptive characteristics, TSH, antibody status and acute diagnosis/treatment. BW score and outcome, was retrospectively calculated using patient notes. Results: BW score was used clinically in 1/51 patients included. Most patients were diagnosed clinically with “acute thyrotoxicosis,” however, the opinion of an endocrinologist was not always sought. Of 29 patients with a BW score indicating ‘storm unlikely’ none were clinically identified at risk of deterioration. Of 15 patients with a BW score suggesting ‘impending storm’, 1 was identified clinically as impending storm. Of 7 patients with a BW score indicating ‘thyroid storm’, 2 were clinically diagnosed with thyroid storm. BW score never suggested a less severe diagnosis, in 6 instances the BW score suggested a more severe diagnosis than the clinical decision. A weak positive correlation between BW score and fT4 was noted (spearman co-efficient: 0.28, P<0.05). Conclusions: The use of the BW score in clinical practice would standardise classification of patients; subsequently, identifying patients at higher risk of clinical deterioration, requiring prompt treatment. As a result of this first audit cycle, we are discussing with clinical biochemistry issuing reports to recommend endocrinology review and encourage use of BW scale where appropriate.